Stay updated on Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new publication citation about the safety and efficacy of dupilumab in infants and young children with atopic dermatitis was added to the Publications section, and an older online-ahead-of-print citation for the same topic was removed.
    Difference
    0.1%
    Check dated 2026-05-31T00:11:38.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the page rendering or metadata. No study details are changed.
    Difference
    0.0%
    Check dated 2026-05-16T09:05:30.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Updated the Publications section to replace the 'Online ahead of print' citation with the final published Paediatr Drugs article (May 2026) on long-term safety and efficacy of dupilumab in young children, including its DOI. The prior April 2, 2026 'Online ahead of print' citation for the same article was removed.
    Difference
    0.0%
    Check dated 2026-05-08T23:38:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page’s displayed site revision/version was updated from v3.5.2 to v3.5.3, reflecting a change to the ClinicalTrials.gov interface build rather than the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T17:05:28.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:35:37.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Publication added to the Publications section: Long-Term Safety and Efficacy of Dupilumab Treatment in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis, Paediatr Drugs, 2026 Apr 2 (Online ahead of print).
    Difference
    0.0%
    Check dated 2026-04-10T08:50:18.000Z thumbnail image

Stay in the know with updates to Long-term Safety of Dupilumab in Pediatric AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Dupilumab in Pediatric AD Clinical Trial page.